Glenmark’s Acetaminophen and Ibuprofen Tablets, 250 mg/125 mg (OTC), will be distributed in the U.S. by Glenmark Therapeutics, USA
The QC Lab is equipped with advanced instruments to ensure rigorous quality control across all manufacturing processes
The drug will be manufactured at the group's topical manufacturing facility at Changodar, Ahmedabad (India)
Keimed is a leading wholesale pharma distribution with industry leading operating metrics
New solvent-free micronization technology expanded at the Darmstadt site in Germany
If approved in the European Union, Fruquintinib will be the first novel targeted therapy for Metastatic Colorectal Cancer regardless of biomarker status in over a decade
Additional data in pregnant adults who are Virologically suppressed reinforce safety and tolerability profile of Biktarvy in broad range of people with HIV
The proposed facility is expected to be operational around January, 2027
Sales reflect continued strong growth in oncology and vaccines
The company will closely work with the USFDA to address and respond to the observations in an expeditious manner
Subscribe To Our Newsletter & Stay Updated
